4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-22-035656
President and CEO sold 20,000 shares at $10.75 ($215,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jiang Wenbin President and CEO | 2022-06-07 | Sale | −20,000 | $10.75 | $215,000 | 7,881,541 | D |
| Open-market sales · 20,000 sh · avg $10.75 · $215,000 | |||||||
Loading xslF345X03/doc4.xml…